Bacterial Aminopeptidase-Activated Peptide Prodrug Enables Species-Selective Targeting of Pseudomonas aeruginosa

Qingtian Gong1, Silvia Synowsky2, Aisling Lynch3,4

  • 1Biomolecular Sciences building, School of Biology, University of St Andrews, North HaughKY16 9ST, U.K.

ACS Infectious Diseases
|August 21, 2026
PubMed

Insights

New antimicrobial peptide prodrugs show promise for treating Pseudomonas aeruginosa infections. Engineered for activation by a specific bacterial enzyme, these prodrugs demonstrate targeted bacterial killing with reduced resistance potential.

Area of Science:

  • Microbiology
  • Biochemistry
  • Drug Discovery

Background:

  • Antimicrobial resistance in Pseudomonas aeruginosa necessitates novel therapeutic strategies.
  • Cationic antimicrobial peptides (AMPs) are potent but lack selectivity and can cause host toxicity.
  • Targeted activation of AMPs could overcome limitations and enhance efficacy.

Purpose of the Study:

  • To design and evaluate AMP prodrugs activated by the Pseudomonas aeruginosa enzyme PaAP for species-specific antimicrobial therapy.
  • To assess the activity of prodrugs against planktonic and biofilm forms of P. aeruginosa.
  • To investigate the mechanisms of activation and resistance development.

Main Methods:

  • Design and synthesis of two D-Bac8CLeu2,5 AMP prodrug variants (EEEE-D-Bac8CLeu2,5 and ELEG-D-Bac8CLeu2,5).
  • In vitro testing of prodrug activation by purified PaAP and P. aeruginosa strains.
  • Antimicrobial activity assays against planktonic cells and biofilms.
  • Analysis of resistance development and cross-resistance patterns.

Main Results:

  • The ELEG-D-Bac8CLeu2,5 prodrug demonstrated rapid and efficient activation by PaAP, restoring potent bactericidal activity.
  • PaAP-mediated activation was crucial for killing P. aeruginosa in biofilms, influencing kinetics.
  • The prodrug exhibited selective activity against P. aeruginosa with reduced efficacy against other ESKAPEE pathogens.
  • Distinct resistance mutations emerged for the prodrug compared to the parent AMP, indicating limited cross-resistance.

Conclusions:

  • Aminopeptidase-activated AMP prodrugs represent a viable strategy for species-selective antimicrobial therapy.
  • Exploiting bacterial enzymes like PaAP enables controlled activation of AMPs.
  • This approach offers a promising alternative for combating challenging P. aeruginosa infections and overcoming resistance.

Related Concept Videos

Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...